ClinicalTrials.gg
Drug

Trametinib clinical trials

Also written GSK1120212 and JTP-74057.

Includes 7 studies of Trametinib dimethyl sulfoxide.

studies test it
166
open now
29
in phase 3
10
first study started
2008

How each study uses trametinib is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the trametinib studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
29 May 2013 · MEKINIST · NDA 204114 (FDA, Drugs@FDA; as trametinib dimethyl sulfoxide)
European Union
30 Jun 2014 · Mekinist · EMEA/H/C/002643 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Trametinib
123
Mekinist
51
MEK Inhibitor GSK1120212
16
Trametinib tablet
6
Trametinib dimethyl sulfoxide
2

Development codes

GSK1120212
48
JTP-74057
18
TMT212
9
SNR1611
1
JTP-78296
1
JTP-75303
1

In one entry with another drug

Given together, or one or the other

Dabrafenib+Trametinib
2

Studies by the year they started

165 studies that test it; most in 2018 (20); 1 more planned to start later

Studies that test trametinib, by start year
YearStudies
20081
20093
20108
20117
20128
201312
201418
201510
20169
201716
201820
20196
202011
202111
20223
20235
20248
20257
20262

By phase

A phase 1/2 study counts in both.

Early Phase 1
2
Phase 1
68
Phase 2
103
Phase 3
10
Phase 4
3
No phase
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 52 · Other 114

GlaxoSmithKline (26) · Novartis Pharmaceuticals (20) · National Cancer Institute (NCI) (17) · M.D. Anderson Cancer Center (8) · Memorial Sloan Kettering Cancer Center (5) · University of California, San Francisco (5) · Melanoma Institute Australia (3) · The Netherlands Cancer Institute (3)

Often tested with

Tested in the same studies.

Dabrafenib (58) · Nivolumab (8) · Pembrolizumab (8) · Palbociclib (6) · Hydroxychloroquine (5) · Binimetinib (4) · Pertuzumab (4) · Trastuzumab (4)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 1 phase 3 study under way

Trametinib is the comparator. A study of two new drugs counts under both.

  • 1Cabozantinib · ECOG-ACRIN Cancer Research Group · next primary completion Sep 2030
Reaching primary completion within a year · 12

Studies that test trametinib.

Studies

Open first, then newest update. How each study uses trametinib is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 166

See all 166 studies that test trametinib →

Given beside what is tested · 71 — trametinib is usual care or a partner of the new treatment

Showing 20 of 71.

As the comparator · 1 — what is tested is compared with trametinib

Codes

What other systems call trametinib · ClinicalTrials.gg INT005875

  • MeSH (NLM) C560077trametinibConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 33E86K87QNTRAMETINIBConfirmed FDA, NLM, Wikidata
  • RxNorm 1425099Confirmed FDA, Wikidata
  • Wikidata Q7833138trametinibConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C77908TrametinibOne source FDA
  • DrugBank DB08911One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.